{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:20:43Z","timestamp":1793049643278,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006041","name":"Innovate UK","doi-asserted-by":"publisher","award":["Project No. 56969"],"award-info":[{"award-number":["Project No. 56969"]}],"id":[{"id":"10.13039\/501100006041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","award":["INNO4COV-19 (Grant agreement No 101016203)"],"award-info":[{"award-number":["INNO4COV-19 (Grant agreement No 101016203)"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["ICMx"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>A prompt and effective immune response is required for clearance of pathogens but exaggerated states of inflammation can cause extensive collateral damage to the host. We have previously used a rapid near-patient assay that measures the functional capacity of neutrophils to produce reactive oxygen species (ROS) to show that values are elevated in patients with severe COVID-19 or sepsis. Here, we assess the utility of longitudinal ROS measurements to monitor and predict mortality outcome for patients with COVID-19 infection being treated in an ICU setting.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We used the Leukocyte ImmunoTest\u2122 (LIT\u2122) to quantify neutrophil ROS release using a small volume (10\u00a0\u00b5L) of capillary blood in a portable, rapid (10-min) format.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>ROS values (LIT score) and ROS levels assessed in relation to neutrophil count (LIT\/N) were both markedly elevated in the patient group. Furthermore, these correlated strongly with peripheral neutrophil count and CRP value. Serial measurement of neutrophil or CRP values were not able to reliably predict mortality within the study. In contrast, LIT and LIT\/N values started to decline at 7 and 5\u00a0days, respectively, in patients who survived ICU admission and this increment increased further thereafter.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study raises the possibility of LIT and LIT\/N to be used as a predictive clinical tool for patients with severe COVID-19 and argues for its assessment to inform on prognosis, and potentially guide treatment pathways, in other disorders associated with neutrophil activation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Take-home message<\/jats:title>\n                <jats:p>A longitudinal study of 44 severe COVID-19 patients in the ICU of a leading teaching hospital has demonstrated the prognostic potential of a rapid bedside assay of neutrophil-derived reactive oxygen species (ROS). Assessment of changes in ROS production, as measured using the Leukocyte ImmunoTest<jats:sup>\u2122<\/jats:sup>, shows that ROS production generally declined back to normal levels for patients who survived, but remained elevated for those patients who did not survive.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40635-023-00554-y","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T13:01:42Z","timestamp":1696597302000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessing neutrophil-derived ROS production at the bedside: a potential prognostic tool in severe COVID-19 cases"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4264-9249","authenticated-orcid":false,"given":"Nazl\u0131han Boyac\u0131","family":"D\u00fcndar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4302-5454","authenticated-orcid":false,"given":"David","family":"Sarphie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4297-5876","authenticated-orcid":false,"given":"Kenan","family":"Y\u00fcce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6472-9429","authenticated-orcid":false,"given":"\u00dcmm\u00fcg\u00fcls\u00fcm","family":"Gayg\u0131s\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8299-2397","authenticated-orcid":false,"given":"O. Tolga","family":"Kaskat\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4043-7082","authenticated-orcid":false,"given":"Melda","family":"T\u00fcrko\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8856-5019","authenticated-orcid":false,"given":"G\u00fclbin Aygencel","family":"B\u0131kmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6009-8324","authenticated-orcid":false,"given":"Lale","family":"Karab\u0131y\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7257-6453","authenticated-orcid":false,"given":"Kayhan","family":"\u00c7a\u011flar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6036-6819","authenticated-orcid":false,"given":"G\u00fclendam","family":"Bozday\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5247-9875","authenticated-orcid":false,"given":"Rubina","family":"Mian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6895-1967","authenticated-orcid":false,"given":"Paul","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1367-6328","authenticated-orcid":false,"given":"Mustafa Necmi","family":"\u0130lhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,6]]},"reference":[{"issue":"14","key":"554_CR1","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1001\/jama.2020.3072","volume":"323","author":"C Del Rio","year":"2020","unstructured":"Del Rio C, Malani PN (2020) COVID-19-new insights on a rapidly changing epidemic. JAMA 323(14):1339\u20131340. https:\/\/doi.org\/10.1001\/jama.2020.3072","journal-title":"JAMA"},{"issue":"10","key":"554_CR2","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","volume":"26","author":"DM Del Valle","year":"2020","unstructured":"Del Valle DM, Kim-Schulze S, Huang H-H et al (2020) An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med 26(10):1636\u20131643. https:\/\/doi.org\/10.1038\/s41591-020-1051-9","journal-title":"Nat Med"},{"issue":"5","key":"554_CR3","doi-asserted-by":"publisher","first-page":"ofaa153","DOI":"10.1093\/ofid\/ofaa153","volume":"7","author":"G Wang","year":"2020","unstructured":"Wang G, Wu C, Zhang Q et al (2020) C-reactive protein level may predict the risk of COVID-19 aggravation. Open Forum Infect Dis 7(5):ofaa153. https:\/\/doi.org\/10.1093\/ofid\/ofaa153","journal-title":"Open Forum Infect Dis"},{"key":"554_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cca.2020.03.022","volume":"506","author":"G Lippi","year":"2020","unstructured":"Lippi G, Plebani M, Henry BM (2020) Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta 506:145\u2013148. https:\/\/doi.org\/10.1016\/j.cca.2020.03.022","journal-title":"Clin Chim Acta"},{"issue":"10229","key":"554_CR5","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395(10229):1033\u20131034. https:\/\/doi.org\/10.1016\/S0140-6736(20)30628-0","journal-title":"Lancet"},{"issue":"5","key":"554_CR6","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen G, Wu D, Guo W et al (2020) Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 130(5):2620\u20132629. https:\/\/doi.org\/10.1172\/JCI137244","journal-title":"J Clin Invest"},{"issue":"7821","key":"554_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","volume":"584","author":"C Lucas","year":"2020","unstructured":"Lucas C, Wong P, Klein J et al (2020) Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 584(7821):463\u2013469. https:\/\/doi.org\/10.1038\/s41586-020-2588-y","journal-title":"Nature"},{"key":"554_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc8511","author":"D Mathew","year":"2020","unstructured":"Mathew D, Giles JR, Baxter AE et al (2020) Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science. https:\/\/doi.org\/10.1126\/science.abc8511","journal-title":"Science"},{"issue":"1","key":"554_CR9","doi-asserted-by":"publisher","first-page":"10484","DOI":"10.1038\/s41598-022-13825-7","volume":"12","author":"T Veenith","year":"2022","unstructured":"Veenith T, Martin H, Le Breuilly M et al (2022) High generation of reactive oxygen species from neutrophils in patients with severe COVID-19. Sci Rep 12(1):10484. https:\/\/doi.org\/10.1038\/s41598-022-13825-7","journal-title":"Sci Rep"},{"issue":"3","key":"554_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nri1312","volume":"4","author":"JD Lambeth","year":"2004","unstructured":"Lambeth JD (2004) NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4(3):181\u2013189. https:\/\/doi.org\/10.1038\/nri1312","journal-title":"Nat Rev Immunol"},{"issue":"13","key":"554_CR11","doi-asserted-by":"publisher","first-page":"8735","DOI":"10.1074\/jbc.R113.544635","volume":"289","author":"H Sies","year":"2014","unstructured":"Sies H (2014) Role of metabolic H2O2 generation: redox signaling and oxidative stress. J Biol Chem 289(13):8735\u20138741. https:\/\/doi.org\/10.1074\/jbc.R113.544635","journal-title":"J Biol Chem"},{"issue":"3","key":"554_CR12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.freeradbiomed.2012.05.006","volume":"53","author":"C Riganti","year":"2012","unstructured":"Riganti C, Gazzano E, Polimeni M, Aldieri E, Ghigo D (2012) The pentose phosphate pathway: an antioxidant defense and a crossroad in tumor cell fate. Free Radic Biol Med 53(3):421\u2013436. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2012.05.006","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"554_CR13","doi-asserted-by":"publisher","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","volume":"24","author":"M Schieber","year":"2014","unstructured":"Schieber M, Chandel NS (2014) ROS function in redox signaling and oxidative stress. Curr Biol 24(10):R453-462. https:\/\/doi.org\/10.1016\/j.cub.2014.03.034","journal-title":"Curr Biol"},{"key":"554_CR14","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200652","author":"BJ Barnes","year":"2020","unstructured":"Barnes BJ, Adrover JM, Baxter-Stoltzfus A et al (2020) Targeting potential drivers of COVID-19: neutrophil extracellular traps. J Exp Med. https:\/\/doi.org\/10.1084\/jem.20200652","journal-title":"J Exp Med"},{"issue":"8","key":"554_CR15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nri3024","volume":"11","author":"A Mantovani","year":"2011","unstructured":"Mantovani A, Cassatella MA, Costantini C, Jaillon S (2011) Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 11(8):519\u2013531. https:\/\/doi.org\/10.1038\/nri3024","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"554_CR16","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.intimp.2013.06.034","volume":"17","author":"K Futosi","year":"2013","unstructured":"Futosi K, Fodor S, M\u00f3csai A (2013) Neutrophil cell surface receptors and their intracellular signal transduction pathways. Int Immunopharmacol 17(3):638\u2013650. https:\/\/doi.org\/10.1016\/j.intimp.2013.06.034","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"554_CR17","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nchembio.85","volume":"4","author":"CC Winterbourn","year":"2008","unstructured":"Winterbourn CC (2008) Reconciling the chemistry and biology of reactive oxygen species. Nat Chem Biol 4(5):278\u2013286. https:\/\/doi.org\/10.1038\/nchembio.85","journal-title":"Nat Chem Biol"},{"key":"554_CR18","doi-asserted-by":"publisher","first-page":"864387","DOI":"10.3389\/fimmu.2022.864387","volume":"13","author":"E McKenna","year":"2022","unstructured":"McKenna E, Wubben R, Isaza-Correa JM et al (2022) Neutrophils in COVID-19: not innocent bystanders. Front Immunol 13:864387. https:\/\/doi.org\/10.3389\/fimmu.2022.864387","journal-title":"Front Immunol"},{"issue":"4","key":"554_CR19","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.immuni.2006.07.016","volume":"25","author":"N Nishida","year":"2006","unstructured":"Nishida N, Xie C, Shimaoka M, Cheng Y, Walz T, Springer TA (2006) Activation of leukocyte beta2 integrins by conversion from bent to extended conformations. Immunity 25(4):583\u2013594. https:\/\/doi.org\/10.1016\/j.immuni.2006.07.016","journal-title":"Immunity"},{"issue":"1","key":"554_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cellimm.2010.02.011","volume":"263","author":"GK Shelton-Rayner","year":"2010","unstructured":"Shelton-Rayner GK et al (2010) Leukocyte reactivity as an objective means of quantifying mental loading during ergonomic evaluation. Cell Immunol 263(1):22\u201330. https:\/\/doi.org\/10.1016\/j.cellimm.2010.02.011","journal-title":"Cell Immunol"},{"issue":"4","key":"554_CR21","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1113\/eph8802571","volume":"88","author":"GW McLaren","year":"2003","unstructured":"McLaren GW et al (2003) Leukocyte coping capacity: a novel technique for measuring the stress response in vertebrates. Exp Physiol 88(4):541\u2013546. https:\/\/doi.org\/10.1113\/eph8802571","journal-title":"Exp Physiol"},{"key":"554_CR22","unstructured":"Fullerton, J. et al (2019) Repurposing the Oxford MediStress Leukocyte Coping CapacityTM assay as a novel point-of-care biomarker of neutrophil function. Presentation British Pharmacological Society Edinburgh, UK"},{"key":"554_CR23","doi-asserted-by":"publisher","DOI":"10.3791\/1724","author":"V Brinkmann","year":"2010","unstructured":"Brinkmann V, Laube B, Abu Abed U, Goosmann C, Zychlinsky A (2010) Neutrophil extracellular traps: how to generate and visualize them. J Vis Exp. https:\/\/doi.org\/10.3791\/1724","journal-title":"J Vis Exp"},{"issue":"3","key":"554_CR24","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1084\/jem.20110367","volume":"208","author":"E Naik","year":"2011","unstructured":"Naik E, Dixit VM (2011) Mitochondrial reactive oxygen species drive proinflammatory cytokine production. J Exp Med 208(3):417\u2013420. https:\/\/doi.org\/10.1084\/jem.20110367","journal-title":"J Exp Med"},{"key":"554_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fimmu.2014.00448","volume":"2014","author":"A Sheshachalam","year":"2014","unstructured":"Sheshachalam A, Srivastava N, Mitchell T, Lacy P, Eitzen G (2014) Granule protein processing and regulated secretion in neutrophils. Front Immunol 2014:5. https:\/\/doi.org\/10.3389\/fimmu.2014.00448","journal-title":"Front Immunol"},{"issue":"3","key":"554_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nri3399","volume":"13","author":"E Kolaczkowska","year":"2013","unstructured":"Kolaczkowska E, Kubes P (2013) Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 13(3):159\u2013175. https:\/\/doi.org\/10.1038\/nri3399","journal-title":"Nat Rev Immunol"}],"container-title":["Intensive Care Medicine Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-023-00554-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40635-023-00554-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-023-00554-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T12:06:27Z","timestamp":1700395587000},"score":1,"resource":{"primary":{"URL":"https:\/\/icm-experimental.springeropen.com\/articles\/10.1186\/s40635-023-00554-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,6]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["554"],"URL":"https:\/\/doi.org\/10.1186\/s40635-023-00554-y","relation":{},"ISSN":["2197-425X"],"issn-type":[{"value":"2197-425X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,6]]},"assertion":[{"value":"10 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Clinical Research Ethics Committee of Gazi University and conducted in the Intensive Care Unit (ICU) of Gazi University Hospital in accordance with the principles of the Declaration of Helsinki, including obtaining informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors Mian and Sarphie declare that they are directors and principal shareholders of Seroxo Ltd, a private company developing clinical applications of the LIT\u2122 system. The other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}